TEKLA CAPITAL MANAGEMENT LLC – Blueprint Medicines Corporation Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$0
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -111.11K shares | -5.61M | $65.89 | 0 |
Q2 2022 | share | Increase | +14.26% | 13.86K shares | -600K | $50.51 | 111.11K |
Q1 2022 | share | Increase | 0.00% | 97.25K shares | 6.21M | $63.88 | 97.25K |
Q3 2021 | share | Decrease | -100.00% | -122.69K shares | -10.79M | $102.81 | 0 |
Q2 2021 | share | 0.00% | 0 shares | -1.13M | $87.96 | 122.69K | |
Q1 2021 | share | 0.00% | 0 shares | -1.83M | $97.23 | 122.69K | |
Q4 2020 | share | Decrease | -27.83% | -47.31K shares | -2M | $112.15 | 122.69K |
Q3 2020 | share | Increase | +43.77% | 51.76K shares | 6.53M | $92.7 | 170.01K |
Q2 2020 | share | Decrease | -15.13% | -21.08K shares | 1.07M | $78 | 118.25K |
Q1 2020 | share | Increase | +19.17% | 22.41K shares | -1.21M | $58.48 | 139.33K |
Q4 2019 | share | Increase | +15.86% | 16.00K shares | 1.95M | $80.11 | 116.92K |
Q3 2019 | share | Increase | +6.25% | 5.94K shares | -1.54M | $73.47 | 100.91K |
Q2 2019 | share | Decrease | -17.93% | -20.74K shares | -304K | $94.33 | 94.97K |
Q1 2019 | share | Decrease | -7.58% | -9.48K shares | 2.51M | $80.05 | 115.72K |
Q4 2018 | share | Decrease | -14.24% | -20.79K shares | -4.64M | $53.91 | 125.20K |
Q3 2018 | share | 0.00% | 0 shares | 2.12M | $78.06 | 146.00K | |
Q2 2018 | share | Increase | +96.71% | 71.78K shares | 2.46M | $63.48 | 146.00K |
Q1 2018 | share | Increase | 0.00% | 74.22K shares | 6.80M | $91.7 | 74.22K |